Project purpose
Pharma.Aero recognizes that staying ahead of new developments, maintaining open communication and industry collaboration is the key to the preparedness of the industry. The project aims to provide additional insights to heighten industry readiness as more COVID-19 vaccines are being manufactured and shipped worldwide, as well as for any new emergencies that might be ahead of us.
Project objective(s)
As a continuation of Project Sunrays, this project seeks to collate insights from the air cargo industry within Pharma.Aero membership on the measures undertaken, their hands-on experience and lessons learned from the initial handling and transportation of the COVID-19 vaccines based on four key requirements: speed, reliability, security, and transparency, and from our Pharma Shippers on how air cargo has responded to the humanitarian task thus far.
Project status and key-takeaways
This project was finalized in June 2021.
The main conclusion, out of the pharma shippers’ feedback is that the air cargo industry has performed generally well during the initial global roll-out of COVID-19 vaccines. Open communication, local and global public and private collaboration and early preparations have played a huge part in ensuring effective handling and air transportation of the shipments. Key action plans and measures have been adopted by the air cargo industry stakeholders around the four key requirements: speed, reliability, security, transparency.
Read more details in the White Paper.
Project support and collaboration
- Pharma.Aero Board liaison and project lead: Changi Airport Group
- Project members: 22 members respondents to the survey and 7 members interviewed